The use of botulinum toxin in head and face medicine: An interdisciplinary field

被引：33
作者：
Laskawi R. [1 ]
机构：
[1] Universitäts-HNO-Klinik, D-37075 Göttingen
来源：
Head & Face Medicine | / 4卷 / 1期
关键词：
Facial Nerve; Masseter Muscle; Botulinum Toxin Type; Blepharospasm; Hemifacial Spasm;
D O I：
10.1186/1746-160X-4-5
中图分类号：
学科分类号：
摘要：
Background. In this review article different interdisciplinary relevant applications of botulinum toxin type A (BTA) in the head and face region are demonstrated. Patients with head and face disorders of different etiology often suffer from disorders concerning their musculature (example: synkinesis in mimic muscles) or gland-secretion. This leads to many problems and reduces their quality of life. The application of BTA can improve movement disorders like blepharospasm, hemifacial spasm, synkinesis following defective healing of the facial nerve, palatal tremor, severe bruxism, oromandibular dystonias hypertrophy of the masseter muscle and disorders of the autonomous nerve system like hypersalivation, hyperlacrimation, pathological sweating and intrinsic rhinitis. Conclusion. The application of botulinum toxin type A is a helpful and minimally invasive treatment option to improve the quality of life in patients with head and face disorders of different quality and etiology. Side effects are rare.
引用
收藏
相关论文
共 37 条
  • [1] Kerner J., Vergiftung durch verdorbene Würste, Tübinger Blätter F Naturwissensch U Arzneykunde, 3, pp. 1-25, (1817)
  • [2] Van Ermengem E., Ber eine neuen anaeroben Bacillus und seine Beziehungen zum Botulismus, Z Hyg Infektionskrankh, 26, pp. 1-56, (1897)
  • [3] Scott A.B., Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery, Opthalmol, 87, 10, pp. 1044-1049, (1980)
  • [4] Truong D.D., Jost W.H., Botulinum toxin: Clinical use, Parkinsonism Relat Disord, 12, pp. 331-55, (2006)
  • [5] Merte R.L., Lanzl I.M., Botulinum toxin injection for production of ptosis, Ophthalmologe, 104, pp. 767-770, (2007)
  • [6] Laskawi R., Rohrbach S., Botulinum toxin in Otolaryngology, HNO, 52, pp. 635-641, (2004)
  • [7] Laskawi R., Damenz W., Roggenkamper P., Baetz A., Botulinum toxin treatment in patients with facial synkinesis, Eur Arch Otorhinolaryngol, SUPPL., pp. 195-199, (1994)
  • [8] Roggenkamper P., Laskawi R., Damenz W., Schroder M., Nugens Z., Orbicular synkinesis after facial paralysis: Treatment with botulinum toxin, Documenta Ophthalmologica, 86, pp. 395-402, (1994)
  • [9] Laskawi R., Combination of hypoglossal-facial nerve anastomosis and botulinum toxin injections to optimize mimic rehabilitation following removal of acoustic neurinomas, Plast Reconstr Surg, 99, pp. 1006-1011, (1997)
  • [10] Laskawi R., Rohrbach S., Rodel R., Surgical and nonsurgical treatment options in patients with movement disorders of the platysma, J Oral Maxillofac Surg, 60, pp. 157-162, (2002)
1234